ArticleThe patient2026

Treatment Preferences for Relapsed/Refractory Mantle Cell Lymphoma Among Patients and Physicians in China: A Discrete Choice Experiment.

Jiachen Shao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.